# SpotLight-19 Research & Development Study

> **NCT05198869** · NA · UNKNOWN · sponsor: **Ottawa Hospital Research Institute** · enrollment: 12500 (estimated)

## Conditions studied

- Screening

## Interventions

- **DEVICE:** Spectral scan

## Key facts

- **NCT ID:** NCT05198869
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-29
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-07-31
- **Target enrollment:** 12500 (ESTIMATED)
- **Last updated:** 2022-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198869, "SpotLight-19 Research & Development Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05198869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*